Financial results - MIRELA PHARM SRL

Financial Summary - Mirela Pharm Srl
Unique identification code: 10178006
Registration number: J1998000072101
Nace: 4773
Sales - Ron
21.962
Net Profit - Ron
-24.019
Employees
1
Open Account
Company Mirela Pharm Srl with Fiscal Code 10178006 recorded a turnover of 2024 of 21.962, with a net profit of -24.019 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Mirela Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 1.113 48.865 152.832 343.717 869.390 1.523.489 2.063.157 454.983 21.962
Total Income - EUR 0 1.113 48.865 152.832 343.717 869.390 1.523.570 2.063.180 454.983 22.823
Total Expenses - EUR 438 802 47.662 133.866 307.541 654.477 1.377.075 1.932.224 419.388 46.843
Gross Profit/Loss - EUR -438 311 1.203 18.966 36.176 214.913 146.495 130.956 35.595 -24.019
Net Profit/Loss - EUR -438 300 714 17.438 32.579 206.174 128.910 115.787 30.749 -24.019
Employees 0 1 3 3 4 3 4 6 2 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -95.1%, from 454.983 euro in the year 2023, to 21.962 euro in 2024. The Net Profit decreased by -30.577 euro, from 30.749 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Mirela Pharm Srl

Rating financiar

Financial Rating -
MIRELA PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Mirela Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Mirela Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Mirela Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Mirela Pharm Srl - CUI 10178006

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 0 0 0 0 0 0 22.929 17.731 799
Current Assets 1.594 1.911 22.840 82.091 133.061 605.275 1.066.552 1.469.922 643.740 596.391
Inventories 0 0 2.839 4.716 12.686 480 93.464 180.561 0 0
Receivables 1.594 1.800 19.162 74.588 120.101 604.150 972.825 1.288.706 640.526 596.364
Cash 0 111 840 2.787 275 645 264 655 3.214 27
Shareholders Funds -10.613 -10.205 -9.319 7.589 42.860 247.967 371.378 488.317 263.375 234.199
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 12.207 12.116 32.159 74.502 90.202 357.308 695.174 1.004.534 398.096 362.990
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 596.391 euro in 2024 which includes Inventories of 0 euro, Receivables of 596.364 euro and cash availability of 27 euro.
The company's Equity was valued at 234.199 euro, while total Liabilities amounted to 362.990 euro. Equity decreased by -27.704 euro, from 263.375 euro in 2023, to 234.199 in 2024.

Risk Reports Prices

Reviews - Mirela Pharm Srl

Comments - Mirela Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.